top
Please input keywords
Order
*Country
한국
미국
일본
중국
영국
호주
프랑스
독일
이탈리아
싱가포르
인도
러시아
캐나다
스위스
기타 국가
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-hANGPTL4 mice plus
Strain Name  C57BL/6JNifdc-Angptl4tm1(ANGPTL4)Bcgen/Bcgen
Common Name  B-hANGPTL4 mice plus
Background C57BL/6J Catalog number 112746
Aliases 

ARP4, FIAF, HARP, HFARP, NL2, PGAR, TGQTL, UNQ171, pp1158

mRNA expression analysis

from clipboard


Strain specific analysis of ANGPTL4 gene expression in wild-type mice and B-hANGPTL4 mice plus by RT-PCR. Mouse Angptl4 mRNA was detectable in fat of wild-type mice (+/+). Human ANGPTL4 mRNA was detectable in heterozygous B-hANGPTL4 mice plus but not in wild-type mice.


Protein expression analysis in serum


from clipboard

Strain specific ANGPTL4 expression analysis in homozygous humanized B-hANGPTL4 mice plus by ELISA. Serum was collected from homozygous B-hANGPTL4 mice plus (H/H) (n=1). Protein expression level of ANGPTL4 was analyzed by ELISA. Human ANGPTL4 was detectable in homozygous B-hANGPTL4 mice plus (H/H). 

Inhibitory efficiency of the nucleic acid drugs against the ANGPTL4 mRNA expression level

from clipboard

The inhibitory efficiency of the nucleic acid drugs against human ANGPTL4 mRNA in liver tissue in B-hANGPTL4 mice plus. B-hANGPTL4 mice plus were randomly divided into two groups (n=3/group, 8 weeks old). The human ANGPTL4 targeted nucleic acid drugs (Provided by the client) and PBS were administered to the mice individually. The nucleic acid drugs was administered in the form of PBS aqueous solution. The drug dosages for all animals were calculated according to the body weight. The mice were sacrificed on day 7, and the liver tissue was collected to detect the expression level of human ANGPTL4 mRNA by qPCR. (A) The schematic diagram of experimental processing. (B) The expression of human ANGPTL4mRNA in liver after treatment. The inhibition rate in the treatment group was 66.7% (The data comes from the client). The human ANGPTL4 in the treatment group (G2) was reduced compared to the control group (G1), demonstrating that B-hANGPTL4 mice plus provide a powerful preclinical model for in vivo evaluation of human ANGPTL4 targeted nucleic acid drugs. Values are expressed as mean ± SEM.